BioCentury | May 6, 2019
Distillery Therapeutics

ADORA2A identified as a thrombosis target

...imaging and myocardial perfusion imaging (MPI) studies. Adenosine Therapeutics LLC markets the ADORA2A agonist Stedivaze apadenoson...
BioCentury | Nov 13, 2014
Distillery Therapeutics

Indication: Endocrine/metabolic disease

...ADORA2A agonist Lexiscan regadenoson as a cardiovascular imaging agent. Adenosine Therapeutics LLC's ADORA2A agonist Stedivaze apadenoson...
BioCentury | Mar 27, 2014
Distillery Therapeutics

Indication: Autoimmune disease

...ADORA2A agonist Lexiscan regadenoson as a cardiovascular imaging agent. Adenosine Therapeutics LLC's ADORA2A agonist Stedivaze apadenoson...
BioCentury | Oct 17, 2013
Distillery Therapeutics

Indication: Endocrine/metabolic disease

...ADORA2A agonists in animal models of NPC1. Adenosine Therapeutics LLC has the ADORA2A agonist Stedivaze apadenoson...
BioCentury | Aug 8, 2013
Distillery Therapeutics

Indication: Cardiovascular disease

...ADORA2A agonist Lexiscan regadenoson as a cardiovascular imaging agent. Adenosine Therapeutics LLC's ADORA2A agonist, Stedivaze apadenoson...
BioCentury | Apr 8, 2013
Company News

Adenosine cardiovascular news

...Needham to explore strategic alternatives for Stedivaze apadenoson, which could include regional or global partners. Stedivaze...
...myocardial perfusion imaging (MPI). Clinical Data acquired substantially all of Adenosine's assets in 2008, including Stedivaze...
...Adenosine declined to disclose details, including the terms under which the company re-acquired rights to Stedivaze...
BioCentury | Jun 21, 2012
Targets & Mechanisms

ADORAble implants

...Inc. ; Pfizer Inc. 's binodenoson, which is in registration; and Forest Laboratories Inc. 's apadenoson...
BioCentury | Jun 14, 2012
Targets & Mechanisms

Beta testing adenosine receptor agonists

...Inc. ; Pfizer Inc. 's binodenoson, which is in registration; and Forest Laboratories Inc. 's apadenoson...
BioCentury | Oct 6, 2011
Cover Story

Opening the brain

...binodenoson in registration for cardiovascular imaging. Forest Laboratories Inc. has the ADORA 2A agonist Stedivaze apadenoson...
BioCentury | Feb 7, 2011
Product Development

Keep It Simple

...of either the product or the company. Clinical Data has two other clinical programs: Stedivaze apadenoson...
Items per page:
1 - 10 of 19